-
721
-
722
-
723
-
724
Antimicrobial susceptibility testing of Dermabacter hominis
Published 2025-01-01Get full text
Article -
725
Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic
Published 2020-01-01Get full text
Article -
726
Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
Published 2020-04-01Get full text
Article -
727
Coagulation Profile of Convalescent Plasma Donors and Recipients
Published 2025-01-01Get full text
Article -
728
-
729
-
730
-
731
-
732
Nucleic Acid Aptamers for Human Norovirus GII.4 and GII.17 Virus-Like Particles (VLPs) Exhibit Specific Binding and Inhibit VLPs from Entering Cells
Published 2025-02-01“…Chao Cheng,1,* Minjia Sun,1– 3,* Jingjing Li,1,* Yitong Xue,1 Xia Cai,4 Jing Liu,1 Xiaolian Wang,5 Shouhong Xu,2 Youhua Xie,1 Junqi Zhang1 1MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, People’s Republic of China; 2Key Laboratory for Advanced Materials and Department of Chemistry, East China University of Science and Technology, Shanghai, 200237, People’s Republic of China; 3Zhejiang CONBA Pharmaceutical Co., Ltd, Hangzhou, 310052, People’s Republic of China; 4Shanghai Medical College, Biosafety Level 3 Laboratory, Fudan University, Shanghai, 200032, People’s Republic of China; 5Department of Pathogeny Microbiology and Preventive Medicine, School of Medicine, Hexi University, Zhangye, 734000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Junqi Zhang, Email junqizhang@fudan.edu.cn; Youhua Xie, Email yhxie@fudan.edu.cnPurpose: Human noroviruses (HuNoVs) are the main cause of non-bacterial acute gastroenteritis. …”
Get full text
Article -
733
-
734
-
735
Pathogen community composition and co-infection patterns in a wild community of rodents
Published 2024-02-01Get full text
Article -
736
-
737
Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
Published 2025-02-01“…Overall, 81% (144/178) of active HCV infections received antiviral treatment, and 89% achieved sustained virological response. The proportion of active HCV infections between the HITTs was 7.2% through reception testing.Conclusion A follow-up HITT after 4 years yielded only 0.3% active HCV infection in a high HCV prevalence prison and a reasonably good reception testing and treatment programme. …”
Get full text
Article -
738
-
739
-
740